Eisai Co., Ltd. has announced a strategic investment of approximately £48 million at its manufacturing site in Hatfield, Hertfordshire, United Kingdom. This investment, supported by the UK Government's Life Sciences Innovative Manufacturing Fund (LSIMF), aims to establish supply chain and packaging capabilities for medicines requiring cold-chain management, including lecanemab. The LSIMF is a capital grants scheme designed to enhance life […]















